Pyrazolo[1,5-a]pyridine-5-carbonitrile

Catalog No. :
ACFVJT240
CAS No. :
1352903-96-8
Molecular Formula :
C8H5N3
Molecular Weight :
143.15

IUPAC Name:pyrazolo[1,5-a]pyridine-5-carbonitrile

Pyrazolo[1,5-a]pyridine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$56.00Login to see priceIn stockInquiry
1g95%$221.00Login to see priceIn stockInquiry
5g95%$918.00Login to see priceIn stockInquiry
25g95%$3782.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyrazolo[1,5-a]pyridine-5-carbonitrile
IUPAC Namepyrazolo[1,5-a]pyridine-5-carbonitrile
MDL No.MFCD21603614
Molecular FormulaC8H5N3
Molecular Weight143.15
SMILESN#CC1=CC2=CC=NN2C=C1
InChI KeyZFBQRIPCGDCQDF-UHFFFAOYSA-N
SynonymCEC90396 | PYRAZOLO[1,5-A]PYRIDINE-5-CARBONITRILE | AMY30473 | 1352903-96-8 | CS-0157275 | DTXSID60857158 | SCHEMBL14311939 | BS-50424 | SY273826 | MFCD21603614
CAS No.1352903-96-8
PubChem CID71741644

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFVJT240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADTG620 route compound structure diagram
    ACADTG6201060812-84-1 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACFVJT240 route product structure diagram
    ACFVJT2401352903-96-8 In Stock
Inquiry

2. ACFVJT240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADTG620 route compound structure diagram
    ACADTG6201060812-84-1 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACFVJT240 route product structure diagram
    ACFVJT2401352903-96-8 In Stock
Inquiry

Comments (0)